Melatonin Inhibits Hypoxia-Induced Alzheimer’s Disease Pathogenesis by Regulating the Amyloidogenic Pathway in Human Neuroblastoma Cells
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25105225 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Nongnuch Singrang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Chulabhorn Graduate Institute, Bangkok 10210, Thailand. Hauptthemen laut MEDLINE: Melatonin, Alzheimer Disease, Neuroblastoma, Amyloid Precursor Protein Secretases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chulabhorn Graduate Institute.
Themen: Demenz
Abstract (Originalsprache)
Stroke and Alzheimer’s disease (AD) are prevalent age-related diseases; however, the relationship between these two diseases remains unclear. In this study, we aimed to investigate the ability of melatonin, a hormone produced by the pineal gland, to alleviate the effects of ischemic stroke leading to AD by observing the pathogenesis of AD hallmarks. We utilized SH-SY5Y cells under the conditions of oxygen–glucose deprivation (OGD) and oxygen-glucose deprivation and reoxygenation (OGD/R) to establish ischemic stroke conditions. We detected that hypoxia-inducible factor-1α (HIF-1α), an indicator of ischemic stroke, was highly upregulated at both the protein and mRNA levels under OGD conditions. Melatonin significantly downregulated both HIF-1α mRNA and protein expression under OGD/R conditions. We detected the upregulation of β-site APP-cleaving enzyme 1 (BACE1) mRNA and protein expression under both OGD and OGD/R conditions, while 10 µM of melatonin attenuated these effects and inhibited beta amyloid (Aβ) production. Furthermore, we demonstrated that OGD/R conditions were able to activate the BACE1 promoter, while melatonin inhibited this effect. The present results indicate that melatonin has a significant impact on preventing the aberrant development of ischemic stroke, which can lead to the development of AD, providing new insight into the prevention of AD and potential stroke treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chulabhorn Graduate Institute, Bangkok 10210, Thailand.
- Innovative Learning Center, Srinakharinwirot University, Bangkok 10110, Thailand.
- Research Center for Neuroscience, Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom 73170, Thailand.
ORCID-Profile: Nongnuch Singrang, Jiraporn Panmanee
Förderung
- Chulabhorn Graduate Institute
Zitieren
APA
Singrang, N., Nopparat, C., Panmanee, J., & Govitrapong, P. (2024). Melatonin Inhibits Hypoxia-Induced Alzheimer’s Disease Pathogenesis by Regulating the Amyloidogenic Pathway in Human Neuroblastoma Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25105225
Vancouver
Singrang N, Nopparat C, Panmanee J, Govitrapong P. Melatonin Inhibits Hypoxia-Induced Alzheimer’s Disease Pathogenesis by Regulating the Amyloidogenic Pathway in Human Neuroblastoma Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25105225
BibTeX
@article{Singrang2024,
author = {Singrang, Nongnuch and Nopparat, Chutikorn and Panmanee, Jiraporn and Govitrapong, Piyarat},
title = {Melatonin Inhibits Hypoxia-Induced Alzheimer’s Disease Pathogenesis by Regulating the Amyloidogenic Pathway in Human Neuroblastoma Cells},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25105225}
}
EUVIMED